T-CYPHER BIO HOLDINGS LIMITED - Profile & Financials

Accounts Submitted 5 Sept 2025

Confirmation Statement Submitted 3 Sept 2025

Net assets £6.96M £4.80M 2023 year on year

Total assets £7.87M £4.66M 2023 year on year

Total Liabilities £910.37K £136.61K 2023 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

3rd Floor, The Sherard Building Edmund Halley Road The Oxford Science Park Oxford Oxfordshire OX4 4DQ United Kingdom

Office ()

Oxford, Oxfordshire, United Kingdom, Europe

Website

tcypherbio.com

Credit Report

Discover T-CYPHER BIO HOLDINGS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2020–2023)

Cash in Bank

£5.86M

Increased by £4.57M (+354%)

Net Assets

£6.96M

Increased by £4.80M (+222%)

Total Liabilities

£910.37k

Decreased by £136.61k (-13%)

Turnover

N/A

Employees

Increased by 2 (+10%)

Debt Ratio

12%

Decreased by 21 (-64%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

6 Allotments 22,061,674 Shares £11452.76m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
29 Jun 2023	SERIES A PREFERRED	8,262,300	£9.55m	£1.156
5 Oct 2022	DEFERRED CONSOLIDATION	1,795	£0.718	£0
21 Dec 2020	PREFERENCE	1,295	£1677.03m	£1.29m
21 Dec 2020	PREFERENCE	500	£250.00m	£500k
17 Dec 2020	A ORDINARY	8	£6.4	£0.8

Officers

4 active 5 resigned

Show resigned officers

						Status
Claire Brown	Director	British	England	54	25 Aug 2021	Active
Owen Hughes	Director	American	United States	51	1 Nov 2024	Active
Shyam Masrani	Director	British	England	36	29 Jun 2023	Active
Thomas Lars Andresen	Director	Danish	Denmark	53	2 Aug 2021	Active

Shareholders

Shareholders (26)


Vox Health Fund	2.5%	774,638	Preferred Seed	3 Sept 2025
Vox Health Fund	0.5%	150,915	Series A Preferred	3 Sept 2025
Vox Health Fund, Lp	0.4%	124,245	Series A Preferred	3 Sept 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Oxford Sciences Innovation Plc

United Kingdom

Active

Notified 28 Aug 2020

Nature of Control

Ownership Of Shares 50 To 75 Percent
Voting Rights 50 To 75 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

OXFORD SCIENCE ENTERPRISES PLC united kingdom

T-CYPHER BIO HOLDINGS LIMITED Current Company

T-CYPHER BIO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
5 Sept 2025	Accounts	Annual accounts made up to 2024-12-31	View(18 pages)
3 Sept 2025	Confirmation Statement	Confirmation statement made on 2025-07-29 with updates	View(6 pages)
30 Jan 2025	Capital	Allotment of shares (GBP 9,289.77435) on 2024-10-10	View(4 pages)
30 Jan 2025	Capital	Allotment of shares (GBP 13,805.92125) on 2024-10-31	View(4 pages)
8 Nov 2024	Officers	Appointment of Mr Owen Hughes as director on 2024-11-01	View(2 pages)